Study bone loss from steroid use in people with inflammatory disease
Part of Bones, joints & muscles, Hormones & metabolism, Infections, Skin clinical trials.
This study looks at how steroid medicines (called glucocorticoids) affect bone strength in people with long-term inflammatory rheumatic conditions or psoriasis. It may help improve how doctors check and manage osteoporosis risk and bone metabolism over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a long-term inflammatory rheumatic condition or psoriasis (or you’re in the control group without these conditions).
- You have already taken steroid tablets/injections for a while, or your doctor expects you to start a long-term steroid plan.
- You can attend the study’s bone/osteoporosis check process through the required outpatient clinic or referral at Charité.
- You can understand the study information and clearly follow what’s being asked.
- You agree to participate and allow your study data to be stored.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how steroids affect bone health in people with inflammatory joint diseases like rheumatoid arthritis. Researchers will track markers in your blood to see if short-term steroid use impacts your bones.
This study is following people who have been recently diagnosed with polymyalgia rheumatica (a condition causing pain and stiffness in the shoulders and hips) and are starting corticosteroid treatment. The goal is to understand the condition's typical course and outcomes over time.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This study looks at the costs and effects of steroid treatments for inflammatory rheumatic conditions. It involves focus groups to understand patients' experiences with steroid use.
This study talks to children and young people with autoimmune or inflammatory conditions (like juvenile arthritis) who have taken steroids in the past two years. It aims to understand how steroids impact their daily lives and feelings.
This trial studies whether it’s safer or works better to slowly reduce steroids versus stopping them abruptly after long-term use. It may help people who are currently on daily steroid tablets and don’t medically need a taper just to treat their underlying condition.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.